Top ▲

Top ▲

Targets Associated with Immuno Processes - B cell (activation)

Jump to: GPCR | Ion Channels | NHRs | Enzymes | Catalytic Receptors | Transporters | Other Protein Targets |

B cell (activation) Download as CSV
GPCRs
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
ADGRG3
(Adhesion Class GPCRs)
  • B cell differentiation (GO:0030183) ISS
true ADGRG3 is expressed by immune cells. It is required for proper B cell development in the spleen [316] ...
CCR2
(Chemokine receptors)
  • regulation of T cell cytokine production (GO:0002724) ISS
  • positive regulation of T-helper 1 type immune response (GO:0002827) ISS
true CCR2 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation. CCR2 is discussed in relation to immuno-oncology in [2] ...
CCR6
(Chemokine receptors)
  • isotype switching to IgA isotypes (GO:0048290) ISS
true CCR6 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. CCR6 is expressed on a variety of immune cells including memory and regulatory T-cells [154,181] ...
CXCR5
(Chemokine receptors)
  • B cell activation (GO:0042113) IEA
true CXCR5 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
CX3CR1
(Chemokine receptors)
  • adaptive immune response (GO:0002250) ISS
true CX3CR1 is one of more than 20 distinct chemokine receptors expressed in human leukocytes. Chemokines primarily act to promote leukocyte chemotaxis to sites of inflammation.
GPR183
(Class A Orphans with emerging pharmacology)
  • adaptive immune response (GO:0002250) ISS
  • B cell activation involved in immune response (GO:0002312) IBA
  • mature B cell differentiation involved in immune response (GO:0002313) ISS
  • positive regulation of B cell proliferation (GO:0030890) IDA
true Gpr183-deficient mice show a reduction in the early antibody response to a T-dependent antigen. GPR183-deficient B cells fail to migrate to the outer follicle and instead stay in the follicle centre [149,233] ...
Ion Channels
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
TRPM4
(Transient Receptor Potential channels (TRP))
  • regulation of T cell cytokine production (GO:0002724) IDA
true TRPM4 is expressed on human T cells, mouse dendritic cells, human and mouse monocytes/macrophages, and mouse mast cells [229] ...
Nuclear Hormone Receptors
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
RAR-related orphan receptor-γ
(1F. Retinoic acid-related orphans)
  • tolerance induction in gut-associated lymphoid tissue (GO:0002394) ISS
  • T-helper 17 cell differentiation (GO:0072539) ISS
true RORγ is a nuclear receptor transcription factor that acts as an immune cell master control switch (most likely associated with expression of the RORγt isoform). This receptor is an essential regulator of type 17 effector T cell differentiation and function. RORγt inhibitors (antagonists and inverse agonists) [76,104,220,282] ...
Enzymes
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
ADAM17
(M12: Astacin/Adamalysin)
  • germinal center formation (GO:0002467) ISS
  • B cell differentiation (GO:0030183) ISS
true The proteolytic activity of ADAM17 (a type I transmembrane metalloproteinase; a.k.a.TNF-alpha converting enzyme or TACE) is involved in the shedding of the extracellular domains of several transmembrane proteins e.g. cytokines (TNFα), growth factors, receptors (IL-6R and TNF-R for example) and adhesion molecules. Cleavage of substrates, including TNFα, IL-6R and L-selectin, produce pro-inflammatory effects stimulating both innate and acquired immune responses. ADAM17 activity is crucial during development (ADAM17 knockout is embryonic lethal), and it has been shown that the soluble IL-6R/IL-6 complex generates agonist-like signals in a process termed IL-6 trans-signaling. The generation and maintenance of several inflammatory and autoimmune diseases is driven by IL-6 trans-signaling [59] ...
Arginase I
(Arginase)
  • negative regulation of T-helper 2 cell cytokine production (GO:2000552) IEA
true The role of ARG1 in immuno-oncology is reviewed in [2] ...
BMX non-receptor tyrosine kinase
(Tec family)
  • adaptive immune response (GO:0002250) IBA
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [32] ...
Bruton tyrosine kinase
(Tec family)
  • adaptive immune response (GO:0002250) IBA
  • regulation of B cell cytokine production (GO:0002721) TAS
  • regulation of B cell apoptotic process (GO:0002902) TAS
  • B cell activation (GO:0042113) TAS
  • positive regulation of B cell differentiation (GO:0045579) TAS
  • positive regulation of type III hypersensitivity (GO:0001805) IEA
  • positive regulation of type I hypersensitivity (GO:0001812) IEA
  • positive regulation of B cell proliferation (GO:0030890) IEA
  • negative regulation of B cell activation (GO:0050869) IEA
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [32] ...
Caspase 8
(C14: Caspase)
  • B cell activation (GO:0042113) TAS
true Roles of apoptotic caspases extending beyond cell death, for example, mediating cellular immune processes such as inflammasome modulation, necroptosis and pro-inflammatory cytokine processing have been reported [188] ...
cathepsin C
(C1: Papain)
  • T cell mediated cytotoxicity (GO:0001913) IEA
true Cathepsin C (CatC) is a lysosomal cysteine protease that is constitutively expressed at high levels in lung, kidney, liver and spleen. As well as activity in lysosomal protein degradation, cathepsin C also plays a key role in the activation of granule serine proteases in cytotoxic T cells, natural killer cells (granzymes A and B), mast cells (chymase and tryptase) and neutrophils (cathepsin G, neutrophil elastase, proteinase 3). Dysregulated activation of neutrophil elastase at inflammatory sites induces the release of pro-inflammatoy mediators and can lead to acute tissue injury. This mechanism is recognised as causing lung damage in neutrophil driven conditions such as asthma and COPD, and has driven the pharmaceutical industry to search for cathepsin C inhibitors with clinical utility (e.g. brensocatib; formerly AZD7986 and INS1007).

SARS-CoV-2 and COVID-19: CatC has been proposed as a drug target to combat ARDS-associated inflammatory lung damage in patients with severe COVID-19. In this setting CatC inhibitors would be expected to protect the lungs from ARDS by reducing the observed virally-induced hyperinflammation that leads to diffuse alveolar collapse and pulmonary tissue damage [157] ...
cathepsin H
(C1: Papain)
  • T cell mediated cytotoxicity (GO:0001913) ISS
  • adaptive immune response (GO:0002250) IEP
true Cathepsin H may act as a pro-granzyme B convertase [75] ...
cathepsin L
(C1: Papain)
  • adaptive immune response (GO:0002250) IEP
true Cathepsins B, H and L have become important therapeutic targets as their proteolytic activity has been implicated in several pathological inflammatory conditions, such as arthritis and periodontitis. Therefore, pharmacological inhibitors of these enzymes are in development as novel therapeutics.
cathepsin S
(C1: Papain)
  • adaptive immune response (GO:0002250) IEP
true Cathepsin S is expressed in the lysosome of antigen presenting cells (dendritic cells, B-cells and macrophages) where it processes the invariant chain-MHC-II complex (a chaperone protein that prevents premature peptide loading) inside antigen presenting cells and in this way controls antigen presentation. Due to this role in antigen presentation, inhibition of cathepsin S is expected to cause immunosuppression [295] ...
complement C1r
(S1: Chymotrypsin)
  • complement activation, classical pathway (GO:0006958) IDA
true A protease component of the C1-complex of the classical complement pathway.
complement C1s
(S1: Chymotrypsin)
  • complement activation, classical pathway (GO:0006958) IDA
true A protease component of the C1-complex of the classical complement pathway.
CTP synthase 1
(Nucleotide turnover)
  • B cell proliferation (GO:0042100) IMP
true CTPS1 is critical for the proliferation of lymphoid cells [193] ...
enhancer of zeste 2 polycomb repressive complex 2 subunit
(Histone methyltransferases (HMTs))
  • B cell differentiation (GO:0030183) IEA
true EZH2 is involved in hematopoietic stem cell proliferation and differentiation, thymopoiesis and lymphopoiesis, with notable participation in regulating the differentiation and function of T cells. This role suggests potential applications in immune-mediated conditions, including autoimmune disorders [301] ...
eukaryotic translation initiation factor 2 alpha kinase 4
(GCN2 subfamily)
  • positive regulation of adaptive immune response (GO:0002821) ISS
true GCN2 is a so-called 'stress kinase'. It phosphorylates serine 51 on the global transcription factor eIF2α upon activation by uncharged tRNA; tRNAs accumulate when amino acid levels are depleted. Phospho-eIF2α blocks translation to cause proliferative arrest.

GCN2 plays several roles in the immune system. It is required for dendritic cell activation and antigen presentation. The GCN2 stress response is required for both optimal proliferation of CD8+ T cells after antigen stimulation, and trafficking to lymphoid organs, i.e. for normal cytotoxic T cell function [305] ...
IL2 inducible T cell kinase
(Tec family)
  • adaptive immune response (GO:0002250) ISS
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [32] ...
INPP5D
(Inositol polyphosphate phosphatases)
  • positive regulation of B cell differentiation (GO:0045579) IBA
true SHIP1 activators are proposed as novel anti-inflammatory agents e.g. rosiptor (AQX-1125) which is in Phase 2 and 3 clinical trials [218,291] ...
Janus kinase 1
(Janus kinase (JakA) family)
  • T-helper 17 cell lineage commitment (GO:0072540) TAS
true The JAK1 tyrosine kinase is crucial for signaling of certain type I and type II cytokines, via receptors belonging to the IL-2, IL-4 and IL-6 receptor families as well as neurotrophin-1 and leptin receptors (all type I cytokine receptors). JAK1 is also involved in signalling via type I ...
Janus kinase 3
(Janus kinase (JakA) family)
  • B cell differentiation (GO:0030183) ISS
  • negative regulation of T-helper 1 cell differentiation (GO:0045626) ISS
  • negative regulation of T-helper 17 cell lineage commitment (GO:2000329) IDA
true Psoriatic skin samples show elevated JAK3 (and JAK1) expression, with signalling predominantly through STAT3 [8] ...
LYN proto-oncogene, Src family tyrosine kinase
(Src family)
  • B cell proliferation (GO:0042100) ISS
true LYN is a Src family tyrosine kinase, expressed predominantly in hematopoietic cells, but also in neural, liver, and adipose tissues. LYN appears to function as a rheostat to modulate B cell signaling, and can be activating or inhibitory in action, depending on the B cell receptor and interacting protein complement present in particular cells [99,102,299] ...
MALT1 paracaspase
(C14: Caspase)
  • positive regulation of T cell cytokine production (GO:0002726) IMP
  • B cell activation (GO:0042113) IBA
  • positive regulation of T-helper 17 cell differentiation (GO:2000321) ISS
true MALT1 inhibition is considered a tractable mechanism for the treatment of severe autoimmune diseases. The MALT1 inhibitory action of (a.k.a. mepazine) is reported to be effecacious in the mouse experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis [197] ...
mitogen-activated protein kinase kinase kinase 7
(TAK1 subfamily)
  • positive regulation of T cell cytokine production (GO:0002726) IMP
true TAK1 (MAP3K7) mediates signaling downstream of multiple cytokine receptors and is functionally important in mitogen, immune, and inflammatory signaling pathways [77,259] ...
MMP14
(M10: Matrix metallopeptidase)
  • positive regulation of B cell differentiation (GO:0045579) ISS
true MMP14 is included in GtoImmuPdb based on its contribution to degradation of collagenous cartilage matrix in rheumatoid arthritis. An anti-MMP14 antibody, DX-2400 [86] ...
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
(Phosphatidylinositol-4,5-bisphosphate 3-kinase family, Phosphatidylinositol kinases)
  • adaptive immune response (GO:0002250) TAS
  • B cell differentiation (GO:0030183) NAS
  • B cell activation (GO:0042113) TAS
true PI3Kδ is preferentially expressed in cells of hemopoietic lineage and is involved in neutrophil chemotaxis. It is the only PI3K isoform with expression restricted to leukocytes. Genetic and pharmacological inactivation of PI3Kδ indicates its importantance for the function of T cells, B cell, mast cells and neutrophils. PI3kδ is a promising target for drugs for preventing or treating inflammation, autoimmunity and transplant rejection [118] ...
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
(Phosphatidylinositol-4,5-bisphosphate 3-kinase family, Phosphatidylinositol kinases)
  • adaptive immune response (GO:0002250) TAS
true The role of PI3Kγ in immuno-oncology is reviewed in [2] ...
phosphoinositide-3-kinase regulatory subunit 1
(Phosphatidylinositol kinases)
  • B cell differentiation (GO:0030183) NAS
true p85α is included in GtoImmuPdb as it is the regulatory subunit of several PI3Ks (e.g. PI3Kδ and PI3Kγ) with roles in leukocyte biology and therefore important for immunity [183] ...
PLCγ2
(Phosphoinositide-specific phospholipase C)
  • B cell differentiation (GO:0030183) ISS
  • B cell activation (GO:0042113) IDA
true Two structurally similar isoforms of PLCγ are expressed by mast cells (PLCγ1 and PLCγ2). Both are important enzymes in the integrated signalling pathways leading to mast cell activation [107,258] ...
proteasome 20S subunit beta 8
(T1: Proteasome)
  • T-helper 1 cell differentiation (GO:0045063) NAS
  • T-helper 17 cell differentiation (GO:0072539) NAS
true PSMB8 is a component of the immunoproteasome [97] ...
protein kinase C beta
(Alpha subfamily)
  • B cell activation (GO:0042113) ISS
true PKCβ is included in GtoImmuPdb based on its GO immune process associations.
protein kinase C theta
(Delta subfamily)
  • positive regulation of T-helper 17 type immune response (GO:2000318) ISS
true PKC-θ is a novel subfamily PKC found predominantly in hematopoietic cells [18] ...
protein kinase C zeta
(Iota subfamily)
  • positive regulation of T-helper 2 cell cytokine production (GO:2000553) ISS
true PKCζ is included in GtoImmuPdb based on its GO process associations.
protein tyrosine kinase 2 beta
(Fak family)
  • marginal zone B cell differentiation (GO:0002315) ISS
true FAK and Pyk2 are phosphorylated downstream of the T cell antigen receptor (TCR) to bring about receptor-specific (e.g. chemokine and integrin receptors) T cell development and activation [61] ...
protein tyrosine phosphatase non-receptor type 2
(Protein tyrosine phosphatases non-receptor type (PTPN))
  • B cell differentiation (GO:0030183) ISS
true Inhibition of PTPN1/2 promotes T cell-mediated anti-tumour immunity [30,179,349] ...
receptor interacting serine/threonine kinase 2
(Receptor interacting protein kinase (RIPK) family)
  • adaptive immune response (GO:0002250) ISS
true RIPK2 is involved in innate immune responses, mediating pro-inflammatory signaling from the bacterial peptidoglycan-sensing NOD1/NOD2 subfamily of innate immune pattern recognition receptors (PRRs) and signalling downstream from the Toll-like receptor (TLR) family of PRRs. Further evidence suggesting an inflammatory role is the targeting of RIPK2 (along with RIPK1/3) by the IAP family E3 ubiquitin ligases (enzymes playing a critical role in innate immunity) [222] ...
receptor interacting serine/threonine kinase 3
(Receptor interacting protein kinase (RIPK) family)
  • regulation of T cell mediated cytotoxicity (GO:0001914) ISS
  • regulation of adaptive immune response (GO:0002819) ISS
true RIPK1 and RIPK3 are involved in necroptosis and as such are critical regulators of inflammation and cell death [216,247,274,313] ...
sirtuin 1
(Histone deacetylases (HDACs))
  • positive regulation of adaptive immune response (GO:0002821) IDA
true Sirtuin 1 has been suggested as a molecular target for host-directed therapy against Mycobacterium tuberculosis infection by research that shows that activation of sirtuin 1 decreases lung pathology, reduces inflammation, and enhances drug efficacy against Mycobacterium tuberculosis [67] ...
spleen associated tyrosine kinase
(Syk family)
  • adaptive immune response (GO:0002250) ISS
  • positive regulation of B cell differentiation (GO:0045579) IMP
true SYK plays a key role in coupling activated immunoreceptors to downstream cellular responses such as proliferation, differentiation, and phagocytosis. Mast cell, macrophage and B-cell activation (and release of inflammatory modulators) is disrupted by inhibition of SYK-mediated immunoreceptor signalling. Selective SYK inhibitors are being sought for a number of inflammatory conditions including rheumatoid arthritis, B-cell lymphoma and asthma/rhinitis [105,245] ...
tec protein tyrosine kinase
(Tec family)
  • adaptive immune response (GO:0002250) IBA
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [32] ...
TXK tyrosine kinase
(Tec family)
  • adaptive immune response (GO:0002250) ISS
true The TEC family protein tyrosine kinases have been identified as key components of T-cell-receptor activation and signalling. TEC family kinases are expressed predominantly by haematopoietic cells. T cells express ITK, TXK and TEC [32] ...
zeta chain of T cell receptor associated protein kinase 70
(Syk family)
  • adaptive immune response (GO:0002250) TAS
  • B cell activation (GO:0042113) TAS
true ZAP-70 has much lower intrinsic enzyme activity than SYK, and expression is restricted to T cells and NK cells [13] ...
Catalytic Receptors
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
BAFF receptor
(Tumour necrosis factor (TNF) receptor family)
  • positive regulation of B cell proliferation (GO:0030890) IBA
  • B cell costimulation (GO:0031296) IBA
true This is a type III membrane bound receptor for B cell activating factor (BAFF). BAFF enhances B cell survival and hence regulates the peripheral B cell population. It is suggested that overproduction of BAFF may enhance the survival of autoreactive B cells, an effect which may contribute in the path ...
CD27
(Tumour necrosis factor (TNF) receptor family)
  • immunoglobulin mediated immune response (GO:0016064) NAS
  • positive regulation of B cell differentiation (GO:0045579) NAS
  • adaptive immune memory response involving T cells and B cells (GO:0090717) IMP
true CD27 (TNFRSF7) is a co-stimulatory immune checkpoint molecule that is expressed on various immune cells, including T cells and NK (natural killer) cells. The endogenous ligand for CD27 is CD70. CD27 interacts with various TRAF adaptor proteins and apoptosis regulatory protein SIVA (SIVA1). It has been recognized as playing an important role in priming, enhancing and sustaining a productive anti-cancer (CD8 T cell) adaptive immune response. CD27 is an immuno-oncology target [48,306] ...
CD40
(Immune checkpoint catalytic receptors, Tumour necrosis factor (TNF) receptor family)
  • B cell proliferation (GO:0042100) NAS
  • B cell activation (GO:0042113) IBA
  • B cell mediated immunity (GO:0019724) IEA
true CD40 is a stimulatory receptor and a member of the tumor necrosis factor receptor superfamily (TNFRSF). It is expressed on a variety of immune cells, including macrophages, B cells, and dendritic cells (DCs). CD40 plays a key role in the activation of the immune system. Endogenous ligand is CD154 (C ...
Cytokine receptor common β subunit
(IL-3 receptor family)
  • immunoglobulin mediated immune response (GO:0016064) IBA
true This a signal transducing protein subunit shared by the functional receptor heterodimers for the cytokines IL-3, IL-5 and GM-CSF, with each receptor having a unique ligand binding alpha subunit.
death receptor 6
(Tumour necrosis factor (TNF) receptor family)
  • B cell apoptotic process (GO:0001783) ISS
  • adaptive immune response (GO:0002250) ISS
  • negative regulation of B cell proliferation (GO:0030889) ISS
true Expressed predominantly in the thymus, spleen and white blood cells. May play a role in T helper cell activation, inflammation and immune regulation. Signals via the TRADD adaptor protein to the NF-κB and MAPK8/JNK pathways.
Fc fragment of IgE receptor Ia
(Fc epsilon receptors)
  • immunoglobulin mediated immune response (GO:0016064) IBA
  • type I hypersensitivity (GO:0016068) IMP
true The product of the FCεR1A gene is a single-pass type I membrane protein that is a high-affinity receptor for immunoglobulin E (IgE). It is the ligand binding subunit of the tetrameric FCεRI, exhibiting a Kd of ~0.1nM.
Fc fragment of IgE receptor Ig
(Fc epsilon receptors)
  • immunoglobulin mediated immune response (GO:0016064) IBA
true The FCER1G protein is a gamma subunit that is utilised as part of the high affinity IgE receptor (a key complex involved in mediating allergic reactions) and other Fc receptors.
Fc fragment of IgE receptor II
(Fc epsilon receptors)
  • B cell antigen processing and presentation (GO:0002450) IDA
true FcεRII (CD23) is the low-affinity receptor for immunoglobulin E (IgE) with a Kd > 100nM. This protein is a C-type lectin found on mature B cells, activated macrophages, eosinophils, follicular dendritic cells, and platelets. It has no structural similarities with other Fc receptors. FcεRII has functions as both a membrane-bound and as a soluble receptor [150,334] ...
fms related receptor tyrosine kinase 3
(Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family)
  • B cell differentiation (GO:0030183) ISS
true FLT3 is the receptor for the cytokine Flt3 ligand (FLT3LG). Flt3 ligand is a growth factor akin to stem cell factor and colony stimulating factor 1, and is essential for hematopoietic progenitor cell development and expansion of both myeloid and lymphoid lineages. It is one of the growth factor receptors targeted by the chemotherapeutic tyrosine kinase inhibitor sorafenib.
Results from mouse experiments suggest that Flt3 ligand is effective in treating sepsis, by potentiating innate immune functions of dendritic cells and neutrophils and improving T cell function [232] ...
herpes virus entry mediator
(Immune checkpoint catalytic receptors, Tumour necrosis factor (TNF) receptor family)
  • negative regulation of T cell cytokine production (GO:0002725) NAS
  • regulation of T cell tolerance induction to tumor cell (GO:0002846) IDA
  • regulation of B cell proliferation (GO:0030888) NAS
  • negative regulation of adaptive immune memory response (GO:1905675) IDA
true HSV viral envelope glycoprotein D (gD) binds to this protein and thereby gains entry to the cell. HVEM binds to several TRAFadaptor proteins to mediate intracellular signalling and activation of the immune response.
integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
(Integrins)
  • B cell differentiation (GO:0030183) IC
true Integrin subunit alpha 4 is the alpha subunit of the α4β1 lymphocyte homing receptor. The cytoplasmic domain of α4 binds tightly to paxillin, a signaling adaptor protein, and this interaction promotes increased cell migration and inhibits cell spreading [116] ...
Interleukin-12 receptor, β1 subunit
(IL-12 receptor family)
  • positive regulation of T cell mediated cytotoxicity (GO:0001916) ISS
  • positive regulation of T-helper 1 type immune response (GO:0002827) IDA
  • positive regulation of T-helper 17 type immune response (GO:2000318) ISS
  • positive regulation of T-helper 17 cell lineage commitment (GO:2000330) ISS
true This protein is a subunit of both the IL-12 and IL-23 cytokine receptors.
Interleukin-12 receptor, β2 subunit
(IL-12 receptor family)
  • negative regulation of T-helper 1 type immune response (GO:0002826) NAS
  • regulation of B cell proliferation (GO:0030888) NAS
true This protein is a subunit of the functional receptor heterodimer for the IL-12 cytokine.
Interleukin 17 receptor A
(IL-17 receptor family)
  • T-helper 17 type immune response (GO:0072538) NAS
true This protein is a common subunit shared by the heterodimeric receptors for interleukins 17 (A, B , C and F) and 25.
Interleukin 17 receptor B
(IL-17 receptor family)
  • T-helper 17 type immune response (GO:0072538) NAS
true IL17RB is a subunit of the heterodimeric interleukin-25 receptor.
interleukin 17 receptor C
(IL-17 receptor family)
  • T-helper 17 type immune response (GO:0072538) NAS
true This is a subunit of the heterodimeric interleukin-17 receptor.
Interleukin 17 receptor E
(IL-17 receptor family)
  • T-helper 17 type immune response (GO:0072538) NAS
true This is a component of the heterodimeric interleukin-17C receptor.
Interleukin-18 receptor 1
(Immunoglobulin-like family of IL-1 receptors)
  • adaptive immune response (GO:0002250) IBA
  • T-helper 1 cell differentiation (GO:0045063) NAS
  • positive regulation of T-helper 1 cell cytokine production (GO:2000556) IDA
true Interleukin-18 1 protein (IL18R1) is the ligand binding subunit of the functional IL-18 receptor heterodimer.
Interleukin-1 receptor-like 1
(Immunoglobulin-like family of IL-1 receptors)
  • negative regulation of T-helper 1 type immune response (GO:0002826) IEA
true IL1RL1 (ST2) is the ligand binding subunit of the functional receptor for IL-33. It is mainly expressed on mast cells, eosinophils and other immune cells [100] ...
Interleukin 1 receptor, type I
(Immunoglobulin-like family of IL-1 receptors)
  • positive regulation of T-helper 1 cell cytokine production (GO:2000556) IDA
true This is one of the subunits of the functional IL-1 receptor type I heterodimer.
Interleukin 21 receptor
(IL-2 receptor family)
  • immunoglobulin mediated immune response (GO:0016064) NAS
true This is the ligand binding subunit of the functional heterodimeric receptor for interleukin 21.
Interleukin 23 receptor
(IL-12 receptor family)
  • positive regulation of T cell mediated cytotoxicity (GO:0001916) ISS
  • positive regulation of T-helper 1 type immune response (GO:0002827) IDA
  • positive regulation of T-helper 17 type immune response (GO:2000318) ISS
  • positive regulation of T-helper 17 cell lineage commitment (GO:2000330) ISS
true This is one of the subunits of the functional IL-23 receptor heterodimer.
Interleukin 27 receptor, alpha
(IL-6 receptor family)
  • negative regulation of T-helper 1 type immune response (GO:0002826) NAS
  • regulation of B cell proliferation (GO:0030888) NAS
  • negative regulation of T-helper 17 type immune response (GO:2000317) IEA
true This is the ligand binding subunit of the IL-27 receptor heterodimer, a complex with IL6ST (signal transducing subunit).
Interleukin-2 receptor subunit β
(IL-2 receptor family)
  • immunoglobulin mediated immune response (GO:0016064) IBA
true IL2RB is a ligand binding component of the IL-2R and is required to elevate ligand affinity. It also a component of the IL-15R.
Interleukin-2 receptor subunit γ
(IL-2 receptor family)
  • immunoglobulin mediated immune response (GO:0016064) NAS
true IL2RG is a common signal transducing subunit shared by the receptors for several different cytokines, namely the IL-2 receptor heterotrimer, the IL-4 receptor type I, the IL-7 receptor, the IL-9 receptor, the IL-15 receptor and the IL-21 receptor.
Interleukin-6 receptor, α subunit
(IL-6 receptor family)
  • T-helper 17 cell lineage commitment (GO:0072540) ISS
true IL6R polymorphisms are associated with asthma risk [96] ...
Interleukin-6 receptor, β subunit
(IL-6 receptor family)
  • positive regulation of adaptive immune response (GO:0002821) IMP
  • negative regulation of T-helper 1 type immune response (GO:0002826) NAS
  • B cell differentiation (GO:0030183) NAS
  • T-helper 17 cell lineage commitment (GO:0072540) ISS
true This is the common signal transducing subunit shared by members of the IL-6 family of cytokine receptors [251] ...
Interleukin 9 receptor
(IL-2 receptor family)
  • immunoglobulin mediated immune response (GO:0016064) IBA
true The functional IL-9 receptor is a heterodimer of the ligand binding IL-9 receptor subunit and the interleukin 2 receptor γ (IL2RG) subunit. IL2RG is a common signal transducing subunit shared by the receptors for several different cytokines, including those for interleukin-2, -4, -7, and -15. ...
KIT proto-oncogene, receptor tyrosine kinase
(Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family)
  • immature B cell differentiation (GO:0002327) ISS
  • B cell differentiation (GO:0030183) IBA
true Stem cell factor (SCF) and its receptor KIT (c-KIT) play an essential part in mast cell biology. In addition to CSF/KIT-mediated regulation of mast cell development, proliferation and survival, KIT is also reported to be involved in the adhesion of mast cells to human airway epithelial cells (a homing and adhesion role), suggesting a mechanism that could be targeted for anti-asthmatic potential [112] ...
NLRP10
(NOD-like receptor family)
  • positive regulation of T-helper 1 type immune response (GO:0002827) ISS
  • positive regulation of T-helper 17 type immune response (GO:2000318) ISS
true NLRP10 is an intracellular pattern recognition receptor (PRR) that has apoptotic and anti-inflammatory functions [129] ...
NLRP3
(NOD-like receptor family)
  • positive regulation of T-helper 2 cell cytokine production (GO:2000553) ISS
true NLRP3 is a component of the NLRP3 inflammasome, a protein complex which activates caspase-1, and plays an important role in the regulation of inflammation and apoptosis (pyroptosis). Drug-like NLRP3 inhibitors are under investigation as novel therapeutics for the treatment of autoinflammatory diseases and neuroinflammation, as an alternative to anti-IL-1 therapies such as , and [19,189] ...
nucleotide binding oligomerization domain containing 2
(NOD-like receptor family)
  • positive regulation of B cell activation (GO:0050871) IDA
true NOD2 is an intracellular pattern recognition receptor that initiates an immune response to bacterial molecules containing muramyl dipeptide (MDP).

Mutations in NOD proteins are implicated in various inflammatory diseases associated with aberrant NF-κB activity; NF-κB being a major ...
OX40
(Tumour necrosis factor (TNF) receptor family)
  • positive regulation of B cell proliferation (GO:0030890) ISS
true The OX40/OX40L axis is involved in late T cell costimulatory signalling and both partners are transiently expressed following antigen recognition. This checkpoint is particularly important for sustaining the effector function of Th1 and Th2 T cells. Blocking OX40/OX40L is reported to prevent the development of disease in in vivo autoimmune and inflammatory disease models [319] ...
receptor activator of NF-kappa B
(Tumour necrosis factor (TNF) receptor family)
  • adaptive immune response (GO:0002250) IMP
true RANK is the receptor for RANK-ligand (RANKL). It is associated with immune cell function and lymph node development, in addition to bone remodeling and repair, thermal regulation, and mammary gland development. Signals to NF-κB and JNK via TRAF adaptor proteins.
RTP Type C
(Receptor tyrosine phosphatase (RTP) family)
  • negative regulation of T cell mediated cytotoxicity (GO:0001915) ISS
  • B cell differentiation (GO:0030183) ISS
  • positive regulation of B cell proliferation (GO:0030890) IMP
  • B cell proliferation (GO:0042100) ISS
true CD45 is a high molecular weight cell surface glycoprotein expressed by cells of hematopoietic origin. Alternate transcripts lead to expression of isoforms that differ in their extracellular (ligand binding) domain (potentially facilitating differential and/or cell type specific biological functions [78] ...
TACI
(Tumour necrosis factor (TNF) receptor family)
  • negative regulation of B cell proliferation (GO:0030889) IBA
true TACI is a lymphocyte-specific TNF superfamily receptor expressed on B cells. Endogenous ligands include APRIL, BAFF and CAML. Defects in the function of TACI can underlie immunodeficiencies and autoimmune diseases. TACI ligands are molecular targets of approved and investigational biologics that are ...
TLR4
(Toll-like receptor family)
  • T-helper 1 type immune response (GO:0042088) NAS
true TLR4 selectively responds to bacterial endotoxin, Gram-negative bacterial lipopolysaccharides (LPS), and lipooligosaccharides (LOS) [35,239] ...
TLR8
(Toll-like receptor family)
  • immunoglobulin mediated immune response (GO:0016064) TAS
true TLR8 is an endosomal receptor detecting ssRNA [304] ...
TLR9
(Toll-like receptor family)
  • positive regulation of B cell proliferation (GO:0030890) IDA
  • regulation of B cell differentiation (GO:0045577) IDA
  • positive regulation of B cell activation (GO:0050871) IDA
true TLR9 is an endosomal receptor detecting viral and bacterial CpG DNA and genomic DNA from some protozoan species [304] ...
tumor necrosis factor receptor 2
(Tumour necrosis factor (TNF) receptor family)
  • regulation of T cell cytokine production (GO:0002724) ISS
true TNFR2 is a receptor for lymphotoxin-α, and the membrane form of tumour necrosis factor (TNF). It plays a variety of important roles in immune system development and regulation [113,217] ...
Transporters
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
ABCB3
(ABCB subfamily)
  • adaptive immune response (GO:0002250) NAS
true TAP1 (ABCB2) and TAP2 (ABCB3) form a transporter that plays an important role in antigen presentation by major histocompatibility complex class I (MHCI) molecules in the adaptive immune response [265] ...
NRAMP1
(SLC11 family of proton-coupled metal ion transporters)
  • positive regulation of T-helper 1 type immune response (GO:0002827) ISS
true NRAMP1 / SLC11A1 appears to be involved in macrophage antimicrobial action against intracellular pathogens, and although its precise mechanism is not fully resolved, evidence indicates its involvement in the activation of phagocytes and synthesis of proinflammatory cytokines. Polymorphisms in the human SLC11A1 gene have been associated with susceptibility to several infections [44,279,283] ...
Peptide transporter 4
(SLC15 family of peptide transporters)
  • regulation of isotype switching to IgG isotypes (GO:0048302) ISS
true SLC15A4 is an oligopeptide transporter that is expressed in early endosomes. It is critical for signalling via certain pattern recognition receptors (e.g. Toll-like receptors 7-9 and NOD receptors) in immune cell subsets [169] ...
Other Protein Targets
GtoPdb receptor name (family) Process Association Comments GO Associations In GtoImmuPdb Immunopharmacology Comments
advanced glycosylation end-product specific receptor
(Immunoglobulin like domain containing proteins)
  • regulation of T cell mediated cytotoxicity (GO:0001914) IDA
true RAGE is a single chain, membrane bound immunoglobulin type protein [214,262,332] ...
aryl hydrocarbon receptor
(Basic helix-loop-helix (BHLH) TFs)
  • regulation of adaptive immune response (GO:0002819) IDA
  • negative regulation of T cell mediated immune response to tumor cell (GO:0002841) IDA
  • regulation of B cell proliferation (GO:0030888) IDA
true The AhR is activated by small signalling molecules derived from the diet, microorganisms and environmental agents, and when expressed by immune cells, it integrates the effects of the environment and metabolism on the immune response [255] ...
BCL2 apoptosis regulator
(B-cell lymphoma 2 (Bcl-2) protein family)
  • positive regulation of B cell proliferation (GO:0030890) IMP
  • B cell proliferation (GO:0042100) IDA
true The role of Bcl-2 family members in immunity and disease is reviewed in [90] ...
BCL6 transcription repressor
(BTB (POZ) domain containing TFs)
  • regulation of germinal center formation (GO:0002634) NAS
  • negative regulation of B cell apoptotic process (GO:0002903) NAS
true BCL6/corepressor complexes are important for the formation of germinal centers and differentiation and proliferation of lymphocytes. Oncogenic mutations in BCL6 lead to the development of diffuse large B-cell lymphoma cells from germinal center B cells. Disruption of BCL6/corepressor complex formation by pharmacological inhibitors has therefore been identified as a novel drug mechanism with potential for the treatment of autoimmune diseases and cancer [53,58] ...
CD19
(CD molecules)
  • B cell proliferation involved in immune response (GO:0002322) IDA
  • immunoglobulin mediated immune response (GO:0016064) IMP
  • B cell proliferation (GO:0042100) ISS
  • regulation of B cell activation (GO:0050864) IDA
true CD19 is a B cell antigen used as a biomarker for normal and neoplastic B cells, and follicular dendritic cells. Anti-CD19 monoclonal antibodies heve been developed for clinical utility in oncology ( and ), transplantation and autimmune diseases ( ...
CD1d molecule
(CD molecules)
  • positive regulation of T cell mediated cytotoxicity (GO:0001916) IBA
true CD1d is a lipid-binding MHC class I-like protein that is expressed by dendritic cells. CD1d presents self and microbial lipid/glycolipid antigens to unconventional T cells known as invariant natural killer T (iNKT) cells [65,327] ...
CD20 (membrane-spanning 4-domains, subfamily A, member 1)
(CD molecules)
  • B cell differentiation (GO:0030183) IDA
  • B cell proliferation (GO:0042100) NAS
  • B cell activation (GO:0042113) IDA
true CD20 is a B cell antigen, involved in B cell development and maturation to antibody-producing plasma cells [72] ...
CD22
(Other immune checkpoint proteins, CD molecules, SIGLECs (conserved))
  • regulation of B cell proliferation (GO:0030888) ISS
  • B cell activation (GO:0042113) IDA
true CD22 (SIGLEC2) is a B cell I-type (Ig-type) lectin that binds glycans containing sialic acids. It is involved in adhesion and activation, mediates B cell-B cell interactions and may be involved in the localisation of B cells in lymphoid tissues. Most SIGLECs inhibit immune cell activation, via
CD226 molecule
(CD molecules)
  • positive regulation of immunoglobulin mediated immune response (GO:0002891) IDA
true CD226 is an immunoglobulin-like adhesion molecule. It is a co-stimulatory partner for the PVR cell adhesion molecule (CD155). CD226 is expressed on T cells, NK cells and platelets. The CD155-CD226/TIGIT axis forms an immune checkpoint that has emerged as a target for tumour immunotherapy (to combat tumour immunoevasion) [228,328,348] ...
CD300a
(CD molecules)
  • negative regulation of B cell proliferation (GO:0030889) IMP
true CD300a is a member of the CD300 family of leucocyte surface receptors [41] ...
CD38
(CD molecules, Abscisic acid receptor complex)
  • positive regulation of B cell proliferation (GO:0030890) IMP
true CD38 is a type II transmembrane glycoprotein, that is widely expressed on immune cells and is involved in cell adhesion and signal transduction. Its extracellular domain acts as an ectoenzyme, catalyzing the conversion of nicotinamide adenine dinucleotide (NAD+) into nicotinamide, adenosine diphosphate-ribose (ADPR), and cyclic ADPR. Expression of CD38 is tightly regulated during B-cell development and maturation [115] ...
CD3e
(CD molecules)
  • adaptive immune response (GO:0002250) NAS
true CD3e is a subunit of the T cell receptor (TCR)-CD3 complex that mediates T cell receptor signal transduction in response to antigen detection. The TCR complex contains a CD3γ chain (CD3G), a CD3δ chain (CD3D), and two CD3ε chains (CD3E), plus the TCR (that can be α/β, or γ/δ type in the subsets of T cells named after the TCR they express) and the ζ-chain (zeta-chain).

CD3e plays a crucial role in T cell development, highlighted by the discovery that defects in CD3e cause severe immunodeficiency [79,284] ...
CD4
(CD molecules)
  • helper T cell enhancement of adaptive immune response (GO:0035397) IBA
true CD4 is being targeted for clinical utility in inflammatory diseases like rheumatoid arthritis (RA), neoplasms derived from T helper cells (T cell lymphomas and related malignancies), and for anti-HIV potential. Depending on the design of CD4 targeting antibodies, they can produce immunosuppressive effects via activation of Tregs and induction of tolerance, block HIV binding to CD4 to prevent HIV infection, or induce depletion of CD4+ T cells by apoptosis, ADCC, or CDC [155,310] ...
CD55 molecule (Cromer blood group)
(CD molecules)
  • positive regulation of T cell cytokine production (GO:0002726) IDA
true CD55 is a glycoprotein that is crucial for regulation of the complement cascade. Complement proteins are degraded when bound by CD55. Mutations in the CD55 gene drive excessive complement pathway activation that is observed in patients with the ultra-rare and life-threatening hereditary immune disea ...
CD74
(CD molecules)
  • immunoglobulin mediated immune response (GO:0016064) ISS
  • positive regulation of B cell proliferation (GO:0030890) IMP
  • negative regulation of mature B cell apoptotic process (GO:0002906) IEA
true CD74 is a type II transmembrane glycoprotein which associates with the MHC class II α and β chains and directs the transport of class II molecules to lysosomal and endosomal compartments [73] ...
CD79B
(CD molecules)
  • B cell differentiation (GO:0030183) IBA
true CD79B is a component of the multimeric B cell antigen receptor (along with CD79A and a membrane-bound antibody that acts as the antigen recognition moiety). The CD79A/B component is responsible for signal transduction. The B cell antigen receptor complex is reported to be involved in the pathogenesis of various B cell-derived lymphoid cancers [205,264] ...
CD80
(Other immune checkpoint proteins, CD molecules)
  • negative regulation of T cell mediated immunity (GO:0002710) IDA
  • positive regulation of T-helper 1 cell differentiation (GO:0045627) NAS
true CD80 (B7-1) is expressed on dendritic cells and activated B cells and monocytes. It is required to provide a costimulatory signal necessary for T cell activation and survival. CD80 works in concert with CD86 to prime T cells. CD80 binds CD28 and CTLA-4 on T cells. It is the interaction with CTLA-4 t ...
CD86
(Other immune checkpoint proteins, CD molecules)
  • B cell activation (GO:0042113) ISS
true CD86 (B7-2) is a type I membrane immunoglobulin. It is expressed on antigen-presenting cells and in association with CD80 provides the costimulatory signal necessary for T cell activation and survival. CD86 interacts with CD28 or CTLA-4 on T cells. It is the interaction with CTLA-4 that is targeted ...
C-type lectin domain family 6 member A
(C-type lectin-like receptors (CLRs))
  • positive regulation of T-helper 17 type immune response (GO:2000318) ISS
true Dectin-2 is involved in initiating the innate immune response upon recognition of high mannose structures on fungal cell walls. It associates with the ITAM-containing FcRβ adaptor and signals through the Syk, PKCδ, and CARD9-Bcl10-MALT1 pathways to promote cytokine production in response ...
C-type lectin domain family 7 member A
(C-type lectin-like receptors (CLRs))
  • positive regulation of T-helper 17 type immune response (GO:2000318) ISS
true Dectin-1 is a pattern recognition receptor involved in initiating the innate immune response upon recognition of various β(1,3)-linked and β(1,6)-linked glucans from fungi and plants. It mediates phagocytosis and the production of inflammatory mediators [47] ...
cytotoxic T-lymphocyte-associated protein 4 (CD152)
(Other immune checkpoint proteins, CD molecules)
  • negative regulation of B cell proliferation (GO:0030889) IMP
true CTLA-4 is expressed almost exclusively on CD4+ and CD8+ T cells. It functions as an immune checkpoint providing an inhibitory signal as a balance to stimulatory signals of the immune response i.e. it plays a crucial role in the maintenance of T cell homeostasis [198] ...
EP300 lysine acetyltransferase
(Non-enzymatic BRD containing proteins)
  • positive regulation of T-helper 17 cell lineage commitment (GO:2000330) IDA
true CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. PMID: 26261308 ...
Fc gamma receptor IIIa
(CD molecules, Immunoglobulin like domain containing proteins)
  • antibody-dependent cellular cytotoxicity (GO:0001788) IDA
true The FCGR3A gene is expressed by natural killer (NK) cells. The protein product (CD16A or FcγRIIIa) is an integral peptide-tethered membrane glycoprotein. FcγRIIIa is a low-affinity receptor for IgG Fc and is involved in removing antigen-antibody complexes from the circulation and antibody-dependent responses.

FcγRIIIa is being exploited for drug development, specifically as a NK cell-engager to mediate NK effector cell killing of cancer cells. For example, Affimed have developed , a tetravalent bispecific Fv peptide construct that simultaneously engages FcγRIIIa and CD30 on CD30-expressing malignant cells such as Hodgkin lymphoma cells, and AFM24 another tetravalent bispecific construct that targets epidermal growth factor receptor (EGFR) and FcγRIIIa to engage NK cells to destroy otherwise hard to treat EGFR-driven cancers.

COVID-19: Analysis of blood from controls and COVID-19 patients was used to show that FcγRIIIa mediates phagocytosis of antibody-opsonised SARS-CoV-2 particles by human monocytes (and macrophages) [139] ...
Fc mu receptor
(Immunoglobulin like domain containing proteins)
  • humoral immune response mediated by circulating immunoglobulin (GO:0002455) ISS
true FcμRI is the cognate Fc receptor for immunoglobulin M (IgM) [162,182,272] ...
immunoglobulin heavy constant epsilon
(Immunoglobulins)
  • antibody-dependent cellular cytotoxicity (GO:0001788) IDA
  • adaptive immune response (GO:0002250) NAS
  • B cell antigen processing and presentation (GO:0002450) IDA
  • complement activation, classical pathway (GO:0006958) IBA
  • type I hypersensitivity (GO:0016068) IDA
  • B cell proliferation (GO:0042100) IDA
  • adaptive immune memory response (GO:0090716) IMP
  • primary adaptive immune response (GO:0090720) IMP
  • B cell activation (GO:0042113) IEA
true IgE is being investigated as a molecular target in allergic inflammatory conditions such as asthma, allergic rhinitis and chronic spontaneous urticaria. One anti-IgE monoclonal, omalizumab, has already been approved for use in patients with asthma or chronic spontaneous urticaria. Omalizumab binds t ...
killer cell lectin like receptor C1 (CD159a)
(CD molecules)
  • negative regulation of T cell mediated cytotoxicity (GO:0001915) IDA
true NKG2A (KLRC1; CD159a) acts as an inhibitory checkpoint receptor for HLA-E. NKG2A forms functional heterodimers with CD94 (KLRD1) to form a human leukocyte antigen E (HLA-E) recognition complex on a subset of natural killer (NK) cells and cytotoxic T cells. NKG2A/CD94/HLA-E binding suppresses immune vigilance, and overexpression of HLA-E is used by cancer cells to evade immune recognition and destruction [84,174,187,275] ...
LAG3 (CD223)
(Other immune checkpoint proteins, CD molecules)
  • negative regulation of T cell mediated immune response to tumor cell (GO:0002841) IDA
true Membrane-bound LAG3 (CD223) is a T cell inhibitory co-receptor and immune checkpoint being investigated as a cancer immunotherapeutic target [10,110] ...
leukocyte immunoglobulin like receptor B1
(CD molecules, Other immune checkpoint proteins)
  • negative regulation of T cell mediated cytotoxicity (GO:0001915) IDA
true LILRB1 (CD85j) is a member of the inhibitory leukocyte immunoglobulin like receptor (LILRB) family (HGNC family 1182). It acts as an inhibitory immune checkpoint for B cell function. Ligands identified for LILRB include native MHC class I proteins, some HLA molecules, pathogen-derived ligands (e.g. from CMV, Dengue virus and some bacteria) and host immunomodulatory proteins such as S100 calcium binding protein A9 (S100A9; P06702; which also binds TLR4 and RAGE) [49] ...
myeloid cell nuclear differentiation antigen
(Absent in melanoma (AIM)-like receptors (ALRs))
  • negative regulation of B cell proliferation (GO:0030889) IMP
true MNDA can be detected exclusively in nuclei of hematopoietic cells of the monocyte lineage. Expression is induced by interferon α [43] ...
NFKB inhibitor zeta
(Inhibitors of NF-kappaB (IκB) family proteins)
  • positive regulation of T-helper 17 cell differentiation (GO:2000321) ISS
  • plasma cell differentiation (GO:0002317) IEA
  • T cell mediated immunity (GO:0002456) IEA
  • B cell proliferation (GO:0042100) IEA
  • T-helper 1 cell differentiation (GO:0045063) IEA
  • isotype switching (GO:0045190) IEA
  • T-helper 17 cell differentiation (GO:0072539) IEA
  • B cell receptor apoptotic signaling pathway (GO:1990117) IEA
true IκBζ is a key component of the immune response that regulates the transcription of a set of inflamatory genes through its association with the p50 or p52 subunits of NF-κB. IκBζ acts as an inhibitor of primary NF-κB response genes, but may also act as a coactivator of the expression of secondary response genes (through association with the NF-κB p50 subunit). IκBζ is in fact the product of a primary NF-κB reponse gene, being rapidly upregulated by various inflammatory stimuli. Pro-inflammatory gene products that are regulated by IκBζ include CCL2, IL-6, IL12p40, IL-17, IFNγ, and GM-CSF [136,147] ...
notch receptor 1
(Notch receptors)
  • T-helper 17 type immune response (GO:0072538) IEA
true NOTCH1 and its ligand Delta-like 4 (DLL4) play a dominant role in mediating the effects of Notch signaling in T cells during Graft-versus-host disease (GvHD). Anti-NOTCH1 or anti-DLL4 antibodies controlled GvHD [300] ...
perforin 1
(Cytolytic pore-forming proteins)
  • T cell mediated cytotoxicity (GO:0001913) ISS
true Perforin 1 is expressed only in the secretory granules of cytotoxic T cells and natural killer (NK) cells, and it is an essential component of the immune system. These cell types release perforin 1 close to target cells (e.g. virus-infected and neoplastic cells) in process known as the granule exocytosis pathway [80] ...
programmed cell death 1 (CD279)
(Other immune checkpoint proteins, CD molecules)
  • negative regulation of T cell mediated immune response to tumor cell (GO:0002841) IDA
true Immune checkpoint blockade in oncology:
Many types of cancer cells evolve mechanisms to evade control and elimination by the immune system. Such mechanisms can include inhibition of so-called 'immune checkpoints', which would normally be involved in the maintenance of immune homeostasis. An increasingly important area of clinical oncology research is the development of new agents which impede these evasion techniques, thereby switching immune vigilance back on, and effecting immune destruction of cancer cells. Three molecular targets of checkpoint inhibitors which are being extensively pursued are cytotoxic T-lymphocyte antigen 4 (CTLA4), programmed cell death 1 (PD-1), and programmed cell death ligand 1 (PD-L1). Using antibody-based therapies targeting these pathways, clinical responses have been reported in various tumour types, including melanoma, renal cell carcinoma [226] ...
PVR cell adhesion molecule
(Immunoglobulin like domain containing proteins)
  • susceptibility to T cell mediated cytotoxicity (GO:0060370) IDA
true The PVR protein (a.k.a. CD155) is a single-pass immunoglobulin-like adhesion molecule. It plays a role in modulating natural killer and T cell-mediated immunity. PVR expression is upregulated in response to exposure to different stimuli, such as Toll-like receptor activation or T cell receptor stimulation [140,330] ...
RAS guanyl releasing protein 1
(EF-hand domain containing proteins)
  • B cell proliferation (GO:0042100) IMP
  • B cell activation (GO:0042113) IMP
true RAS guanyl releasing protein 1 (RASGRP1) functions as a diacylglycerol (DAG)-regulated nucleotide exchange factor. It activates Ras and the downstream Erk/MAP kinase cascade. RASGRP1 regulates the development, homeostasis and differentiation of T aand B cells [111,241,269] ...
signal transducer and activator of transcription 3
(STAT transcription factors)
  • T-helper 17 type immune response (GO:0072538) IDA
  • T-helper 17 cell lineage commitment (GO:0072540) ISS
true STAT3 regulates the expression of a variety of genes in response to cytokines and growth factors (e.g. IFNs, EGF, IL-5, IL-6, HGF, LIF and BMP2) and plays important roles in several cellular processes, including cell growth and apoptosis. STAT3 is a crucial component of the JAK/STAT signalling pathway that is implicated in cancer and inflammation. STAT3 is frequently activated in cancers, where it downmodulates intrinsic immune surveillance of tumour cells. Phosphorylated (activated) STAT3 (pSTAT3) is a marker of poor cancer prognosis [335,340] ...
T-cell surface glycoprotein CD3 zeta chain (CD247)
(CD molecules)
  • adaptive immune response (GO:0002250) NAS
true Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response.
TIM3 (CD366)
(Other immune checkpoint proteins, CD molecules)
  • negative regulation of T-helper 1 type immune response (GO:0002826) IDA
  • regulation of tolerance induction dependent upon immune response (GO:0002652) IEA
true TIM3 is an immunoglobulin type protein expressed exclusively on the surface of differentiated Th1 cells [203] ...
vav guanine nucleotide exchange factor 1
(Rho GEFs)
  • B cell proliferation (GO:0042100) ISS
true VAV1 is a positive regulator of T cell receptor signaling, including IFNγ production and IL-2 secretion.